Reply to Cameron E. Alexander, Ashwin Sachdeva, and Noel W. Clarke’s Letter to Editor Re: Develtere D, Devos G. Metformin in prostate cancer: A negative repurposing story across the disease continuum. Urol Oncol 2026. https://doi.org/10.1016/j.euo.2026.04.014.
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
Reply to Cameron E. Alexander, Ashwin Sachdeva, and Noel W. Clarke’s Letter to Editor Re: Develtere D, Devos G. Metformin in prostate cancer: A negative repurposing story across the disease continuum. Urol Oncol 2026. https://doi.org/10.1016/j.euo.2026.04.014. // European Urology Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2588931126001860?dgcid=rss_sd_all
Reply to Cameron E. Alexander, Ashwin Sachdeva, and Noel W. Clarke’s Letter to Editor Re: Develtere D, Devos G. Metformin in prostate cancer: A negative repurposing story across the disease continuum. Urol Oncol 2026. https://doi.org/10.1016/j.euo.2026.04.014. European Urology Oncology. https://www.sciencedirect.com/science/article/pii/S2588931126001860?dgcid=rss_sd_all
“Reply to Cameron E. Alexander, Ashwin Sachdeva, and Noel W. Clarke’s Letter to Editor Re: Develtere D, Devos G. Metformin in prostate cancer: A negative repurposing story across the disease continuum. Urol Oncol 2026. https://doi.org/10.1016/j.euo.2026.04.014.” European Urology Oncology.
@article{article97969,
title = {Reply to Cameron E. Alexander, Ashwin Sachdeva, and Noel W. Clarke’s Letter to Editor Re: Develtere D, Devos G. Metformin in prostate cancer: A negative repurposing story across the disease continuum. Urol Oncol 2026. https://doi.org/10.1016/j.euo.2026.04.014.},
journal = {European Urology Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2588931126001860?dgcid=rss_sd_all}
}